National PMDT Scale-up Plan - India - 2011-12 - TBC India
National PMDT Scale-up Plan - India - 2011-12 - TBC India
National PMDT Scale-up Plan - India - 2011-12 - TBC India
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>National</strong> <strong>Scale</strong> <strong>up</strong> <strong>Plan</strong> for Programmatic Management of DR TB <strong>2011</strong> - 20<strong>12</strong><br />
– Reduce risk of expiry & exposure to poor storage conditions<br />
– Simplify packing, s<strong>up</strong>ply and reporting by patient months<br />
– Intensify monitoring of enrollments on monthly basis<br />
– Enable better forecasting of drug transfers and procurements<br />
– Enable standardizing specifications for box design at CTD<br />
• Adjust to identified product s<strong>up</strong>ply imbalances; specifically for Cs & Eto for WB states (2350)<br />
• Intensify monitoring of SDS and DDS <strong>up</strong>-gradation<br />
• CTD and SAMS to develop standard curriculum and organize training of SDS Pharmacists on SLD<br />
Drug Stock Management at Ahmedabad<br />
• Share the technical specifications and guidance to states on local purchase of XDR TB drugs.<br />
2. Laboratory <strong>Scale</strong> <strong>up</strong>:<br />
• S<strong>up</strong>port implementation of lab-committee endorsed reforms to the laboratory accreditation<br />
process<br />
• Expedite accreditation visits of Labs awaiting accreditation<br />
• Monitor labs accreditation (Solid/Liquid) and fast-track introduction of LPA rapid diagnostics<br />
with solid culture for follow <strong>up</strong><br />
• S<strong>up</strong>port States to take decisions on lab linkage by states, in coordination with NRLs and<br />
partners; Private labs to address C-DST deficits for preparatory states (BI, CG, GA, HP, JK, KA, PB,<br />
UP, 8NE, 4UTs) and implementing states (DL, GU, RJ, TN)<br />
• Accelerate provision of high throughput hybridization and other efficiency-oriented equipments<br />
to existing LPA labs, in advance of switch to MDR Suspect category B in any area covered by the<br />
laboratory, to help lab stay ahead of expected workload increases.<br />
• Revise of C-DST Scheme to be undertaken to include rapid diagnostic techniques like Liquid<br />
Culture and LPA as well as Second Line Drugs like Ofloxacin / Kanamycin.<br />
• Revise of Sample Pick <strong>up</strong> transport Scheme to include collection and transport of samples in cold<br />
chain within 72 hours to the C-DST laboratory.<br />
• Reiterate the guidance on procurement, installation, AMC of Lab equipments to preparatory<br />
states like Bihar, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Assam, Arunachal Pradesh,<br />
Manipur and Sikkim<br />
• Regularize visits by NRLs with partners to Labs under <strong>up</strong>-gradation<br />
3. Enrollments of MDR TB Suspects and Cases:<br />
• Re-visit enrollment plans of DL and RJ, who currently plan enrollment of cases in excess of their<br />
planned drug capacity, and arrive at solutions with the States.<br />
• Consider delay in switching between suspect criteria in some large states if drug s<strong>up</strong>ply becomes<br />
constrained.<br />
4. DOTS Plus Sites:<br />
• Engage states to fast track civil work <strong>up</strong> gradation in <strong>2011</strong>.<br />
• Installation and maintenance of UVGI to be considered in North and North-East states with cold<br />
climates with s<strong>up</strong>port of PATH (USAID)<br />
• Linking <strong>up</strong> Architects/Engineers trained in “Building Design and Engineering approaches to<br />
Airborne Infection Control” to states for <strong>up</strong>-gradation of DP Site.<br />
38